|
|
Other links at Articles > Business of Medicine |
| 1. |
Hospira Wins European Approval for Retacrit
|
|
|
Hospira Inc said on Wednesday it won European approval to sell Retacrit, a generic version of erythropoietin, as a treatment for anemia associated with chronic renal failure and chemotherapy. Reuters Health Information
|
| 3. |
Medicare Private Plans Underestimate Profits: GAO
|
|
|
Private health plans contracting in the federal Medicare program have underestimated profits, which could inflate government reimbursement, a congressional watchdog group said on Wednesday. Reuters Health Information
|
|
|